1,2-Dichloroethane → tert-Butyl [2-(morpholin-4-yl)-2-oxoethyl]carbamate

HRID 1814739노트

반응식

HRID 1814739 반응식
[C:1]([O:5][C:6]([NH:8][CH2:9][C:10]([OH:12])=O)=[O:7])([CH3:4])([CH3:3])[CH3:2].C(N(CC)C(C)C)(C)C.C(Cl)CCl.C1C=CC2N(O)N=NC=2C=1.[NH:36]1[CH2:41][CH2:40][O:39][CH2:38][CH2:37]1>CN(C=O)C>[C:1]([O:5][C:6](=[O:7])[NH:8][CH2:9][C:10]([N:36]1[CH2:41][CH2:40][O:39][CH2:38][CH2:37]1)=[O:12])([CH3:2])([CH3:3])[CH3:4]

참가 물질

7

실험 절차

To a stirred solution of N-(tert-butoxycarbonyl)glycine (3.0 g, 17.1 mmol) in DMF (75 mL), N,N-diisopropylethylamine (14.9 mL, 85.5 mmol) was added, followed by EDC (3.6 g, 18.8 mmol) and HOBT (2.5 g, 18.8 mmol) at 0° C., under argon. The resulting mixture was stirred for 0.5 h after which time morpholine (3.0 mL, 34.2 mmol) was introduced in a dropwise manner. Upon complete addition, the reaction was warmed to ambient temperature, stirred overnight and concentrated. The resulting residue was diluted with EtOAc and saturated NaHCO3. The layers were separated and the aqueous phase was extracted with EtOAc. The combined organics were dried (MgSO4), filtered and concentrated to give 2.3 g (55%) of (2-morpholin-4-yl-2-oxo-ethyl)-carbamic acid tert-butyl ester which was used without further purification.

후처리

  1. additionwas introduced in a dropwise manner
  2. additionUpon complete addition
  3. concentrationconcentrated
  4. additionThe resulting residue was diluted with EtOAc and saturated NaHCO3
  5. customThe layers were separated
  6. extractionthe aqueous phase was extracted with EtOAc
  7. dry with materialThe combined organics were dried (MgSO4)
  8. filtrationfiltered
  9. concentrationconcentrated

출처 및 근거

ORD 기록
ord-44f71313330d42eeb557bb4c03afbcc1
출처 데이터셋
uspto-grants-2005_04
특허 번호
US06878706B1

반응 노트

불러오는 중…